Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmathene Inc (PIP)

Pharmathene Inc (PIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmathene Inc ONE PARK PLACE SUITE 450 ANNAPOLIS MD 21401 USA

www.pharmathene.com P: 410-269-2600

Description:

PharmAthene Inc. is a biodefense company formed to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene's lead programs include Valortim and Protexia.

Key Statistics

Overview:

Market Capitalization, $K 44,733
Shares Outstanding, K 68,820
Annual Sales, $ 5,230 K
Annual Net Income, $ 193,850 K
Last Quarter Sales, $ 1,120 K
Last Quarter Net Income, $ 77,800 K
60-Month Beta 2.43
% of Insider Shareholders 5.94%
% of Institutional Shareholders 42.67%

Growth:

1-Year Return -72.80%
3-Year Return -56.38%
5-Year Return -53.57%
5-Year Revenue Growth -78.45%
5-Year Earnings Growth -1,382.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/08/17
Earnings Per Share ttm 2.95
EPS Growth vs. Prev Qtr -102.54%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 2.910 on 02/06/17
Dividend Payout Ratio 0.00%

PIP Ratios

Ratio
Price/Earnings ttm 0.24
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 396.23%
Return-on-Assets % 188.24%
Profit Margin % 3,706.50%
Debt/Equity 0.00
Price/Sales 9.27
Price/Cash Flow 0.21
Price/Book 2.48
Book Value/Share 0.31
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar